Skip to content

Clinical trials

Phase 2/3 Arthritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis Phase: Phase 2/3 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20132
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centers for Disease Control and Prevention2
ACELYRIN Inc.1
Corewell Health East1
National Center for Complementary and Integrative Health (NCCIH)1
Olatec Therapeutics, Inc.1
Pfizer1
Prisma Health-Midlands1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis8
Arthritis, Rheumatoid2
Pain2
Arthralgia1
Arthritis, Gouty1
Arthritis, Juvenile1
Arthritis, Psoriatic1
Blood Loss, Surgical1
Gout1
Hemorrhage1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.